STAAR Surgical reported FY 2025 net sales of USD 239.4 million, down 23.7%, and a net loss of USD 80.4 million. Gross profit was USD 182.4 million (gross margin 76.2%), while operating loss was 38.3% of net sales. FY 2025 selling and marketing expense was USD 102.5 million (42.8% of net sales), general and administrative expense was USD 85.8 million (35.8% of net sales), and research and development expense was USD 40.1 million (16.7% of net sales). The company recorded USD 17.1 million in merger transaction and related costs and USD 28.6 million in restructuring, impairment and related charges. STAAR said the sales decline was driven by weaker demand dynamics in China, where aggregate net sales to its two distributors were USD 77.8 million in FY 2025 versus USD 162.3 million in FY 2024. FY 2025 results included USD 27.5 million of net sales tied to a previously disclosed December 2024 China shipment that had extended payment terms and was recognized when paid in FY 2025. On corporate updates, STAAR said its merger agreement with Alcon was terminated effective January 6, 2026 after shareholders voted against the deal, with no termination fee payable; it also disclosed a subsequent cooperation agreement with Broadwood Partners providing for governance and leadership changes and reimbursement by STAAR of approximately USD 7.0 million in expenses. The company also highlighted continued expansion and ramp-up of ICL manufacturing in Nidau, Switzerland, and said it negotiated consignment agreements in China and delivered consigned inventory to mitigate tariff exposure, while ramping Switzerland production to provide manufacturing optionality.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000718937-26-000004), on March 03, 2026, and is solely responsible for the information contained therein.